Talphera, Inc. (TLPH)

USD 0.49

(-2.37%)

Total Liabilities Summary of Talphera, Inc.

  • Talphera, Inc.'s latest annual total liabilities in 2023 was 6.29 Million USD , down -75.5% from previous year.
  • Talphera, Inc.'s latest quarterly total liabilities in 2024 Q2 was 12.12 Million USD , down -2.51% from previous quarter.
  • Talphera, Inc. reported annual total liabilities of 25.67 Million USD in 2022, down -77.44% from previous year.
  • Talphera, Inc. reported annual total liabilities of 113.78 Million USD in 2021, down -6.77% from previous year.
  • Talphera, Inc. reported quarterly total liabilities of 12.43 Million USD for 2024 Q1, up 97.74% from previous quarter.
  • Talphera, Inc. reported quarterly total liabilities of 6.29 Million USD for 2023 FY, down -75.5% from previous quarter.

Annual Total Liabilities Chart of Talphera, Inc. (2023 - 2013)

Created with Highcharts 11.1.0YearsTotal Liabilities201320142015201620172018201920202021202220230 USD50000000 USD100000000 USD150000000 USD

Historical Annual Total Liabilities of Talphera, Inc. (2023 - 2013)

Year Total Liabilities Total Liabilities Growth
2023 6.29 Million USD -75.5%
2022 25.67 Million USD -77.44%
2021 113.78 Million USD -6.77%
2020 122.04 Million USD -8.08%
2019 132.77 Million USD 14.18%
2018 116.28 Million USD 3.76%
2017 112.06 Million USD 6.39%
2016 105.33 Million USD 11.26%
2015 94.67 Million USD 138.11%
2014 39.76 Million USD 7.83%
2013 36.87 Million USD 0.0%

Peer Total Liabilities Comparison of Talphera, Inc.

Name Total Liabilities Total Liabilities Difference
Journey Medical Corporation 56.49 Million USD 88.867%
ANI Pharmaceuticals, Inc. 471.67 Million USD 98.666%
Aquestive Therapeutics, Inc. 163.9 Million USD 96.162%
Pacira BioSciences, Inc. 704.25 Million USD 99.107%
Sunshine Biopharma, Inc. 6.13 Million USD -2.45%
Sunshine Biopharma, Inc. 6.13 Million USD -2.45%
SCYNEXIS, Inc. 55.45 Million USD 88.656%
Safety Shot Inc 3.89 Million USD -61.612%
Alpha Teknova, Inc. 38.55 Million USD 83.684%
Collegium Pharmaceutical, Inc. 947.87 Million USD 99.336%
Bright Green Corporation 6.43 Million USD 2.3%
Dynavax Technologies Corporation 375.02 Million USD 98.323%
Esperion Therapeutics, Inc. 660.79 Million USD 99.048%
Cosmos Health Inc. 30.25 Million USD 79.208%
PainReform Ltd. 2.69 Million USD -133.742%
China SXT Pharmaceuticals, Inc. 9.19 Million USD 31.605%
Embecta Corp. 2.03 Billion USD 99.691%
Intra-Cellular Therapies, Inc. 136.87 Million USD 95.404%
Procaps Group, S.A. 462.06 Million USD 98.639%
Theratechnologies Inc. 98.63 Million USD 93.623%
Harrow Health, Inc. 241.75 Million USD 97.398%
Sonoma Pharmaceuticals, Inc. 8.75 Million USD 28.164%
Biofrontera Inc. 23.13 Million USD 72.816%
DURECT Corporation 30.4 Million USD 79.313%
Supernus Pharmaceuticals, Inc. 487.46 Million USD 98.71%
Cronos Group Inc. 43.73 Million USD 85.618%
OptiNose, Inc. 194.33 Million USD 96.763%
Ironwood Pharmaceuticals, Inc. 817.36 Million USD 99.23%
Kala Pharmaceuticals, Inc. 48.44 Million USD 87.016%
RedHill Biopharma Ltd. 20.97 Million USD 70.016%
Organogenesis Holdings Inc. 181.36 Million USD 96.532%
Guardion Health Sciences, Inc. 3.77 Million USD -66.749%
Cumberland Pharmaceuticals Inc. 52.51 Million USD 88.023%
Radius Health, Inc. 804.29 Million USD 99.218%
Universe Pharmaceuticals INC 13.75 Million USD 54.269%
ProPhase Labs, Inc. 42.54 Million USD 85.215%
Phibro Animal Health Corporation 725.54 Million USD 99.133%
Procaps Group S.A. 462.06 Million USD 98.639%
Alvotech 1.88 Billion USD 99.666%
TherapeuticsMD, Inc. 14.02 Million USD 55.142%
Viatris Inc. 27.21 Billion USD 99.977%
Rockwell Medical, Inc. 30.88 Million USD 79.632%
Aytu BioPharma, Inc. 90.37 Million USD 93.04%
SIGA Technologies, Inc. 57.97 Million USD 89.151%
Tilray Brands, Inc. 892.11 Million USD 99.295%
Lifecore Biomedical, Inc. 219.8 Million USD 97.138%
Shineco, Inc. 47.6 Million USD 86.786%
PetIQ, Inc. 645.22 Million USD 99.025%
Regencell Bioscience Holdings Limited 219.51 Thousand USD -2765.447%
Incannex Healthcare Limited 5.83 Million USD -7.89%
Neurocrine Biosciences, Inc. 1.01 Billion USD 99.383%
Alimera Sciences, Inc. 107.35 Million USD 94.141%
Silver Spike Investment Corp. 3 Million USD -108.982%
Assertio Holdings, Inc. 148.41 Million USD 95.762%
Shuttle Pharmaceuticals Holdings, Inc. 1.89 Million USD -231.757%
Petros Pharmaceuticals, Inc. 21.31 Million USD 70.491%
Clever Leaves Holdings Inc. 7.02 Million USD 10.475%
Cyclo Therapeutics, Inc. 8.49 Million USD 25.917%
Avadel Pharmaceuticals plc 173.38 Million USD 96.372%
Hempacco Co., Inc. 18.82 Million USD 66.582%
Alvotech 1.88 Billion USD 99.666%
Eagle Pharmaceuticals, Inc. 172.6 Million USD 96.356%
Lantheus Holdings, Inc. 835.25 Million USD 99.247%
Currenc Group, Inc. 177.67 Million USD 96.46%
Kamada Ltd. 109.96 Million USD 94.28%
Indivior PLC 1.95 Billion USD 99.678%
Evoke Pharma, Inc. 9.64 Million USD 34.806%
Flora Growth Corp. 17.22 Million USD 63.477%
Cyclo Therapeutics, Inc. 8.49 Million USD 25.917%
Evolus, Inc. 209.68 Million USD 97.0%
HUTCHMED (China) Limited 536.38 Million USD 98.827%
Amphastar Pharmaceuticals, Inc. 873.49 Million USD 99.28%
Akanda Corp. 12.66 Million USD 50.351%